Particulars |
|
|
|
Company Name
| Aurobindo Pharma Ltd
| Year End
| 202403
|
Full Year |
Equity (₹ Cr.) |
58.59 |
B.V. (₹) |
335.50 |
Sales(₹ Cr.) |
10,645.64 |
NP (₹ Cr.) |
1,952.97 |
NP Var (%) |
60.00 |
Div% |
450.00 |
CPS(₹) |
37.70 |
EPS (₹) |
33.30 |
Traded Value(₹ Lakhs) |
161.28 |
52 Week High |
1,593.00 |
52 Week Low |
959.00 |
Price BSE |
1,215.00 |
Price NSE |
1,215.00 |
Market Capital (₹ Cr.) |
71,200.33 |
P/C Ratio |
32.20 |
P/E Ratio |
36.50 |
Price Vs.BV |
3.62 |
|
Latest Quarter |
Year End |
202409 |
Sales (₹ Cr.) |
2,757.88 |
NP(₹ Cr.) |
537.53 |
NP Var % |
42.00 |
Trailing Twelve Months |
Year End |
202409 |
Sales |
10,713.37 |
OPM |
23.11 |
NP |
2,069.02 |
NP Var (%) |
27.75 |
EPS |
35.31 |
PE |
34.41 |
|
|